Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 15.6 | 6.1 | 2.3 | 5.0 |
| Revenue growth | 154.9% | 164.8% | -53.8% | |
| Cost of goods sold | 2.0 | 3.0 | 1.9 | 1.7 |
| Gross profit | 13.6 | 3.1 | 0.4 | 3.4 |
| Gross margin | 87.2% | 51.1% | 18.9% | 66.9% |
| Research and development | 7.6 | 4.1 | 4.4 | 3.9 |
| General and administrative | 5.9 | 4.7 | 3.7 | 3.7 |
| EBIT | 0.1 | -5.6 | -7.6 | 4.2 |
| EBIT margin | 0.4% | -91.2% | -329.2% | 84.7% |
| Pre-tax income | 0.2 | -5.8 | -11.2 | -6.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 0.2 | -5.8 | -11.2 | -6.2 |
| Net margin | 1.5% | -94.1% | -481.6% | -124.6% |
| |
| Diluted EPS | $0.02 | ($0.84) | ($2.24) | ($1.43) |
| Shares outstanding (diluted) | 12.0 | 6.9 | 5.0 | 4.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|